Saturday, December 05, 2020 10:45:00 PM
Recent BCRX News
- BioCryst Launches ORLADEYO® (berotralstat) in Ireland • GlobeNewswire Inc. • 11/18/2024 07:00:09 AM
- BioCryst to Present at Upcoming Investor Conferences • GlobeNewswire Inc. • 11/06/2024 12:00:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/05/2024 10:19:10 PM
- BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 11/05/2024 12:00:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/04/2024 12:06:59 PM
- BioCryst Reports Third Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/04/2024 12:00:00 PM
- BioCryst Presents New Real-World Evidence Showing High Adherence and Persistence Rates with ORLADEYO® (berotralstat) • GlobeNewswire Inc. • 10/24/2024 12:00:00 PM
- BioCryst to Report Third Quarter 2024 Financial Results on November 4 • GlobeNewswire Inc. • 10/21/2024 11:00:23 AM
- BioCryst to Present New Real-World Evidence Showing Significant Reductions in Medical Visits and Hospitalizations After Starting ORLADEYO® (berotralstat) • GlobeNewswire Inc. • 10/14/2024 11:00:00 AM
- BioCryst to Present New Real-World Evidence on Long-Term Prophylaxis in HAE, including ORLADEYO® (berotralstat), at the American College of Allergy, Asthma & Immunology 2024 Annual Scientific Meeting • GlobeNewswire Inc. • 10/10/2024 11:00:00 AM
- BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 10/03/2024 11:00:53 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2024 11:06:38 AM
- BioCryst Begins Enrollment in Phase 1 Trial Evaluating BCX17725, a KLK5 Inhibitor, for the Treatment of Netherton Syndrome • GlobeNewswire Inc. • 10/02/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/30/2024 11:11:26 AM
- U.S. Government Awards BioCryst $69 Million RAPIVAB® (peramivir injection) Contract for Strategic National Stockpile • GlobeNewswire Inc. • 09/30/2024 11:00:00 AM
- BioCryst and the pan-Canadian Pharmaceutical Alliance (pCPA) Successfully Complete Negotiations for ORLADEYO® (berotralstat), an Oral, Once-daily Therapy for the Prevention of Hereditary Angioedema Attacks • GlobeNewswire Inc. • 09/17/2024 11:00:00 AM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 09/10/2024 04:09:00 PM
- BioCryst Presents New ORLADEYO® (berotralstat) Data at 7th Bradykinin Symposium • GlobeNewswire Inc. • 09/06/2024 06:00:11 AM
- BioCryst Appoints Dr. Donald Fong Chief Medical Officer • GlobeNewswire Inc. • 09/05/2024 11:00:00 AM
- BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 09/04/2024 11:00:46 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:17:53 PM
- BioCryst to Present at Upcoming Investor Conferences • GlobeNewswire Inc. • 08/22/2024 11:00:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/06/2024 08:38:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/05/2024 11:05:05 AM
- BioCryst Reports Second Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/05/2024 11:00:24 AM
FEATURED North Bay Resources Announces Production of Gold Concentrate and Refinery Shipment at Bishop Gold Mill, California • Nov 18, 2024 9:00 AM
One World Products Sets New Standards in Sustainability With Strategic Hemp Innovations • OWPC • Nov 18, 2024 7:54 AM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM